In addition to elevated circulating MPO levels in CAD patients, increased levels of active MPO and biomarkers indicative of oxidative tissue damage by MPO-derived oxidants are found in human atherosclerotic lesions of CAD patients, thereby identifying MPO as a source of oxidative stress in diseased arteries [68,69]. This evidence concerns the gene MPO and coronary artery disorder.